MA12.06 STELLAR – Final Results of a Phase 2 Trial of TTFields With Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

OA08.02 DREAM - A Phase 2 Trial of Durvalumab With First Line Chemotherapy in Mesothelioma: Final Result

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

Chemotherapy for Malignant Pleural Mesothelioma: Past Results and Recent Developments

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2004English

Multimodality Treatment of Malignant Pleural Mesothelioma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

P2.06-10 Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Retrospective Study of Palliative Cisplatin-Based Doublet Chemotherapy for Malignant Pleural Mesothelioma

Cancer and Clinical Oncology
2014English

Malignant Pleural Mesothelioma With Pleural Plaques: A Case Report

The Bangkok Medical Journal
2018English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

194TiP: LUNAR: Phase III Study of Front-Line Chemotherapy With TTFields for Advanced Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy